"10.1371_journal.pone.0034805","plos one","2012-04-12T00:00:00Z","Anna Bobrowska; Gizem Donmez; Andreas Weiss; Leonard Guarente; Gillian Bates","Department of Medical and Molecular Genetics, King's College London, London, United Kingdom; Paul F. Glenn Laboratory and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; Neuroscience Discovery, Novartis Institutes for BioMedical Research, Basel, Switzerland","Conceived and designed the experiments: AB AW GPB. Performed the experiments: AB AW. Analyzed the data: AB AW GPB. Contributed reagents/materials/analysis tools: GD AW LG GPB. Wrote the paper: AB GPB. Proofread the manuscript: GD AW LG.","The authors have read the journal's policy and have the following conflicts: AW is an employee of Novartis Pharma AG, Basel, and GD received a fellowship from Johnson and Johnson. The CHDI Foundation is a privately-funded not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. BioFocus, Cerep, Cychem and Pharmidex provided reagents and data through a fee-for-service agreement for the CHDI Foundation. This declaration does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials.","2012","04","Anna Bobrowska","AB",5,TRUE,3,2,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
